AI-driven revenue-cycle management and claims automation for specialty-care clinics.
Camber builds revenue-cycle infrastructure for specialty-care providers, automating the insurance-claims lifecycle — eligibility checks, claim creation, pre-submission scrubbing, denial management, appeals and payment posting — for clinics in applied behavior analysis (ABA), physical therapy, speech-language pathology and ENT/allergy. Its rules engine is trained on more than $2.5B in real claims data across its provider network, so each denial produces a payer-specific rule that improves subsequent claims, with human insurance specialists handling escalations and edge cases. The company was founded in 2021 as Juniper (Y Combinator Winter 2021), grew out of an ABA clinic run as a proof of concept, and rebranded to Camber in 2025. It came out of stealth in February 2025 alongside a $30M Series B led by Andreessen Horowitz, disclosing $50M raised to date, 90,000 patients billed for across 42 states, roughly $2B in annual billables under management and a 93% first-pass paid rate. It reports 500+ providers served and a 95%+ first-pass paid rate as of 2026, and has said it intends to expand into home health, long-term care and substance-use-disorder care.
Healthcare📍 New York, NYFounded 2021
Current Valuation
Private
PRIVATE
IPO Outlookprivate
Is Camber going public?
No. Camber is private and has not filed to go public. There is no S-1 on file.
What is Camber's valuation in 2026?
No confirmed valuation is on record for Camber. The roster shows funding and investors where they are public; it does not estimate a mark.
Has Camber filed an S-1?
No public S-1 is on file for Camber.
Who are Camber's investors?
Camber's investors include Andreessen Horowitz, Craft Ventures, ACME, Y Combinator, K Ventures, Manresa.
How much has Camber raised?
Camber has raised $50M in total across 4 disclosed rounds, most recently a Series B of $30M in Feb 2025.
Is Camber publicly traded — can you buy Camber stock?
No. Camber is a private company — its shares are not listed on any exchange and there is no ticker. The routes to exposure are pre-IPO secondary marketplaces and funds (accredited investors), employee tender offers when the company runs one, and public companies with read-through exposure. QuantLogix maps every route it can verify for Camber on its Pre-IPO Access Desk.
Answers are derived from the roster record shown on this page — filing status, last round and confirmed marks. Where the record is silent, the answer says so rather than guessing.
Company Profile
CEO
Christophe Rimann
Founded
2021
HQ
New York, NY
Employees
85
Total Raised
$50M
Growth
Scaled from a single ABA clinic to billing for 90,000 patients across 42 states and ~$2B in annual billables; claims data trained on has grown to $2.5B+ and headcount to ~85
Last Round
Series B — $30M (Feb 2025) · Lead: Andreessen Horowitz
IPO Status
private
Fundraising Status
Series B · $30M · 1y 7mo ago
privateTotal raised $50M4 disclosed rounds
Growth & Valuation
Capital raised per round
Charts built from publicly disclosed funding rounds and revenue estimates. Approximate, not real-time, not investment advice.
Funding History
Round
Amount
Date
Lead Investor
Post-Money
Series B
$30M
Feb 2025
Andreessen Horowitz
—
Seed
$3M
May 2021
Craft Ventures
—
Pre-Seed
$125,000
Mar 2021
Y Combinator
—
Series A
—
Andreessen Horowitz
—
Talent Signal
Hiring trend
▲ Hiring uptrend
+15% vs 2026-08
Open roles
15
via ashby
Product-build share
53%
engineering, research, product, design
Trajectory
scaling
product-led hiring — 53% of open roles build product; the rest are go-to-market and G&A.
Executive bench growing while hiring expands: 1 senior hire (CFO); open roles trending up.
Open roles by month
Open roles by function
■ product-building ■ go-to-market / G&A
Key Executive Moves
INPeter CoatsCFO · 2026-09-02
From trusted-source news extraction (deep-enrich pipeline); dates approximate publication, not effective date.
Counted from Camber's live job board as of 2026-09-14; role functions classified from posting titles. Open-role counts are an activity signal, not headcount. Refreshed monthly.
Founders & Key People
Christophe RimannCelina QiNathan Lee
Investors
Andreessen Horowitz · Craft Ventures · ACME · Y Combinator · K Ventures · Manresa
Products
Revenue cycle management platform for specialty-care clinics
Camber Rules Engine (payer-specific claim scrubbing and denial prediction)
Claims creation, pre-submission scrub and electronic submission
Denial management and appeals automation
Payment posting and reconciliation
Eligibility and prior-authorization verification
Revenue analytics and payer-contract benchmarking
Competitors
Candid Health · Adonis · Waystar · CentralReach · Availity
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of recent date. Refreshed quarterly.